Filters
Other countries
Results: 1 to 20 of 20
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
SP110 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 2 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 323 | 329 |
|
Invitae Inborn Errors of Immunity and Cytopenias Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 754 | 562 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Labcorp Genetics (formerly Invitae) LabCorp United States | 177 | 130 |
|
Invitae Primary Immunodeficiency Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 552 | 424 |
|
Integrated Genetics Westborough LabCorp United States | 330 | 746 |
|
Targeted Variant, Fetal Analysis Integrated Genetics Westborough LabCorp United States | 292 | 746 |
|
Integrated Genetics Westborough LabCorp United States | 287 | 578 |
|
Integrated Genetics Westborough LabCorp United States | 292 | 597 |
|
Integrated Genetics Westborough LabCorp United States | 330 | 746 |
|
Integrated Genetics Westborough LabCorp United States | 287 | 578 |
|
Hepatic Veno-Occlusive Disease With Immunodeficiency (SP110 Single Gene Test) Fulgent Genetics United States | 2 | 1 |
|
Comprehensive Primary Immunodeficiency NGS Panel Fulgent Genetics United States | 1048 | 472 |
|
B-Positive Severe Combined Immunodeficiency NGS Panel Fulgent Genetics United States | 38 | 26 |
|
Severe Combined Immunodeficiency NGS Panel Fulgent Genetics United States | 330 | 90 |
|
Hepatic Veno-Occlusive Disease with Immunodeficiency: gene sequencing CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 1 | 1 |
|
Syndromes with immunodeficiency Panel CeGaT GmbH Germany | 33 | 38 |
|
Fulgent Genetics United States | 2 | 1 |
|
Fulgent Genetics United States | 5128 | 4672 |
|
Results: 1 to 20 of 20
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.